By Drug Type: Prescription Dominance Reinforced by Payer Mandates Prescription products represented 64.53% of the anti-obesity drugs market in 2025, and the cohort is on track for a 32.85% CAGR through 2031
Brands can provide tailored products for people who are using GLP-1 drugs, including small servings of fitness formulations and products that relieve the drugs common gastrointestinal side effects, says Jennifer Zegler, director of food and drink at Mintel
doi: 10.20944/preprints202311.1505.v1 278
Further, acetylcarnitine facilitates acetylcholine production in the striatum and hippocampus 51
Moreover, GLP-1 and its analogs have shown positive effects in kidney protection, neuroprotection, and lipid metabolism regulation, and they hold promise in treating conditions like non-alcoholic steatohepatitis (NASH) and Alzheimer's disease
Drug-Phospholipid Complex-a Go Through Strategy for Enhanced Oral Bioavailability - PubMed